Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction
BackgroundMyocardial infarction (MI) is a common cardiovascular disease (CVD) in critically ill patients, leading to 17% mortality in the intensive care unit (ICU) setting. Patients with CVD frequently suffer from thiamine insufficiency, thereby thiamine supplements may be helpful. Unfortunately, th...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-08-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2023.1227974/full |
| _version_ | 1827856339507871744 |
|---|---|
| author | Suru Yue Suru Yue Jia Wang Jia Wang Yumei Zhao Yumei Zhao Enlin Ye Dongdong Niu Jiasheng Huang Xiaolin Li Yiling Hu Xuefei Hou Xuefei Hou Jiayuan Wu Jiayuan Wu |
| author_facet | Suru Yue Suru Yue Jia Wang Jia Wang Yumei Zhao Yumei Zhao Enlin Ye Dongdong Niu Jiasheng Huang Xiaolin Li Yiling Hu Xuefei Hou Xuefei Hou Jiayuan Wu Jiayuan Wu |
| author_sort | Suru Yue |
| collection | DOAJ |
| description | BackgroundMyocardial infarction (MI) is a common cardiovascular disease (CVD) in critically ill patients, leading to 17% mortality in the intensive care unit (ICU) setting. Patients with CVD frequently suffer from thiamine insufficiency, thereby thiamine supplements may be helpful. Unfortunately, the relationship between thiamine treatment and survival outcomes in ICU patients with MI is still unknown. The purpose of the research is to demonstrate the survival advantage of thiamine application in these patients.MethodsThe Medical Information Mart of Intensive Care-IV database served as the foundation for this retrospective cohort analysis. Depending on whether patients were given thiamine therapy during the hospital stay, critically ill MI patients were split into the thiamine and non-thiamine groups. The Kaplan–Meier (KM) method and Cox proportional hazard models were used to evaluate the relationship between thiamine use and the risk of in-hospital, 30-day, and 90-day mortality. To validate the results, a 1:2 closest propensity-score matching (PSM) was also carried out.ResultsThis study included 1782 patients for analysis with 170 and 1,612 individuals in the thiamine and non-thiamine groups, respectively. The KM survival analyses revealed that the risk of in-hospital, 30-day, and 90-day mortality was significantly lower in the thiamine group than the none-thiamine group. After modifying for a variety of confounding factors, the Cox regression models demonstrated substantial positive impacts of thiamine use on in-hospital, 30-d, and 90-d mortality risk among critically ill patients with MI with hazard ratio being 0.605 [95% confidence interval (CI): 0.397–0.921, p = 0.019], 0.618 (95% CI: 0.398–0.960, p = 0.032), and 0.626 (95% CI: 0.411–0.953, p = 0.028), respectively, in the completely modified model. PSM analyses also obtained consistent results.ConclusionThiamine supplementation is related to a decreased risk of mortality risk in critically ill patients with MI who are admitted to the ICU. More multicenter, large-sample, and well-designed randomized controlled trials are needed to validate this finding. |
| first_indexed | 2024-03-12T12:23:20Z |
| format | Article |
| id | doaj.art-0cf64c7f9ed0458aa4824ddafaa253b5 |
| institution | Directory Open Access Journal |
| issn | 2296-861X |
| language | English |
| last_indexed | 2024-03-12T12:23:20Z |
| publishDate | 2023-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Nutrition |
| spelling | doaj.art-0cf64c7f9ed0458aa4824ddafaa253b52023-08-30T04:50:41ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-08-011010.3389/fnut.2023.12279741227974Thiamine administration may increase survival benefit in critically ill patients with myocardial infarctionSuru Yue0Suru Yue1Jia Wang2Jia Wang3Yumei Zhao4Yumei Zhao5Enlin Ye6Dongdong Niu7Jiasheng Huang8Xiaolin Li9Yiling Hu10Xuefei Hou11Xuefei Hou12Jiayuan Wu13Jiayuan Wu14Clinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaGuangdong Engineering Research Center of Collaborative Innovation of Clinical Medical Big Data Cloud Service in Western Guangdong Medical Union, Affiliated Hospital of Guangdong Medical University, Zhanjian, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaGuangdong Engineering Research Center of Collaborative Innovation of Clinical Medical Big Data Cloud Service in Western Guangdong Medical Union, Affiliated Hospital of Guangdong Medical University, Zhanjian, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaGuangdong Engineering Research Center of Collaborative Innovation of Clinical Medical Big Data Cloud Service in Western Guangdong Medical Union, Affiliated Hospital of Guangdong Medical University, Zhanjian, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaGuangdong Engineering Research Center of Collaborative Innovation of Clinical Medical Big Data Cloud Service in Western Guangdong Medical Union, Affiliated Hospital of Guangdong Medical University, Zhanjian, Guangdong, ChinaClinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, ChinaGuangdong Engineering Research Center of Collaborative Innovation of Clinical Medical Big Data Cloud Service in Western Guangdong Medical Union, Affiliated Hospital of Guangdong Medical University, Zhanjian, Guangdong, ChinaBackgroundMyocardial infarction (MI) is a common cardiovascular disease (CVD) in critically ill patients, leading to 17% mortality in the intensive care unit (ICU) setting. Patients with CVD frequently suffer from thiamine insufficiency, thereby thiamine supplements may be helpful. Unfortunately, the relationship between thiamine treatment and survival outcomes in ICU patients with MI is still unknown. The purpose of the research is to demonstrate the survival advantage of thiamine application in these patients.MethodsThe Medical Information Mart of Intensive Care-IV database served as the foundation for this retrospective cohort analysis. Depending on whether patients were given thiamine therapy during the hospital stay, critically ill MI patients were split into the thiamine and non-thiamine groups. The Kaplan–Meier (KM) method and Cox proportional hazard models were used to evaluate the relationship between thiamine use and the risk of in-hospital, 30-day, and 90-day mortality. To validate the results, a 1:2 closest propensity-score matching (PSM) was also carried out.ResultsThis study included 1782 patients for analysis with 170 and 1,612 individuals in the thiamine and non-thiamine groups, respectively. The KM survival analyses revealed that the risk of in-hospital, 30-day, and 90-day mortality was significantly lower in the thiamine group than the none-thiamine group. After modifying for a variety of confounding factors, the Cox regression models demonstrated substantial positive impacts of thiamine use on in-hospital, 30-d, and 90-d mortality risk among critically ill patients with MI with hazard ratio being 0.605 [95% confidence interval (CI): 0.397–0.921, p = 0.019], 0.618 (95% CI: 0.398–0.960, p = 0.032), and 0.626 (95% CI: 0.411–0.953, p = 0.028), respectively, in the completely modified model. PSM analyses also obtained consistent results.ConclusionThiamine supplementation is related to a decreased risk of mortality risk in critically ill patients with MI who are admitted to the ICU. More multicenter, large-sample, and well-designed randomized controlled trials are needed to validate this finding.https://www.frontiersin.org/articles/10.3389/fnut.2023.1227974/fullmyocardial infarctioncardiovascular diseasethiaminecritically ill patientsmortality riskMIMIC-IV database |
| spellingShingle | Suru Yue Suru Yue Jia Wang Jia Wang Yumei Zhao Yumei Zhao Enlin Ye Dongdong Niu Jiasheng Huang Xiaolin Li Yiling Hu Xuefei Hou Xuefei Hou Jiayuan Wu Jiayuan Wu Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction Frontiers in Nutrition myocardial infarction cardiovascular disease thiamine critically ill patients mortality risk MIMIC-IV database |
| title | Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| title_full | Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| title_fullStr | Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| title_full_unstemmed | Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| title_short | Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| title_sort | thiamine administration may increase survival benefit in critically ill patients with myocardial infarction |
| topic | myocardial infarction cardiovascular disease thiamine critically ill patients mortality risk MIMIC-IV database |
| url | https://www.frontiersin.org/articles/10.3389/fnut.2023.1227974/full |
| work_keys_str_mv | AT suruyue thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT suruyue thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT jiawang thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT jiawang thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT yumeizhao thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT yumeizhao thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT enlinye thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT dongdongniu thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT jiashenghuang thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT xiaolinli thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT yilinghu thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT xuefeihou thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT xuefeihou thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT jiayuanwu thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction AT jiayuanwu thiamineadministrationmayincreasesurvivalbenefitincriticallyillpatientswithmyocardialinfarction |